{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:46:03Z","timestamp":1767771963618,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"15-16","license":[{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00508-020-01747-1","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T01:03:11Z","timestamp":1602032591000},"page":"832-839","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Utility of procalcitonin in a\u00a0medical intensive care unit in Croatia"],"prefix":"10.1007","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9374-429X","authenticated-orcid":false,"given":"Ana","family":"Vujaklija Brajkovi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iva","family":"Ko\u0161uta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dora","family":"Tomek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mia","family":"Rora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jak\u0161a","family":"Babel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dunja","family":"Rogi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Lon\u010dar Vran\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radovan","family":"Radoni\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,6]]},"reference":[{"issue":"6","key":"1747_CR1","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","volume":"34","author":"A Kumar","year":"2006","unstructured":"Kumar\u00a0A, Roberts\u00a0D, Wood\u00a0KE, Light\u00a0B, Parrillo\u00a0JE, Sharma\u00a0S, et\u00a0al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589\u201396.","journal-title":"Crit Care Med"},{"issue":"9","key":"1747_CR2","first-page":"194","volume":"63","author":"S Fridkin","year":"2014","unstructured":"Fridkin\u00a0S, Baggs\u00a0J, Fagan\u00a0R, Magill\u00a0S, Pollack\u00a0LA, Malpiedi\u00a0P, et\u00a0al. Vital signs: improving antibiotic use among hospitalized patients. Mmwr Morb Mortal Wkly Rep. 2014;63(9):194\u2013200.","journal-title":"Mmwr Morb Mortal Wkly Rep"},{"issue":"9713","key":"1747_CR3","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0140-6736(09)61879-1","volume":"375","author":"L Bouadma","year":"2010","unstructured":"Bouadma\u00a0L, Luyt\u00a0C\u2011E, Tubach\u00a0F, Cracco\u00a0C, Alvarez\u00a0A, Schwebel\u00a0C, et al. Use of procalcitonin to reduce patients\u2019 exposure to antibiotics in intensive care units (PRORATA trial): a\u00a0multicentre randomised controlled trial. Lancet. 2010;375(9713):463\u201374.","journal-title":"Lancet"},{"issue":"9","key":"1747_CR4","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1097\/CCM.0b013e31821e8791","volume":"39","author":"JU Jensen","year":"2011","unstructured":"Jensen\u00a0JU, Hein\u00a0L, Lundgren\u00a0B, Bestle\u00a0MH, Mohr\u00a0TT, Andersen\u00a0MH, et al. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a\u00a0randomized trial. Crit Care Med. 2011;39(9):2048\u201358.","journal-title":"Crit Care Med"},{"key":"1747_CR5","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/1471-2334-13-178","volume":"13","author":"E Assink-de Jong","year":"2013","unstructured":"Assink-de Jong\u00a0E, de Lange\u00a0DW, van Oers\u00a0JA, Nijsten\u00a0MW, Twisk\u00a0JW, Beishuizen\u00a0A. Stop antibiotics on guidance of procalcitonin study (SAPS): a\u00a0randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a\u00a0standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients\u2014calculated sample size: 1816\u00a0patients. BMC Infect Dis. 2013;13:178.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"1747_CR6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00423-008-0432-1","volume":"394","author":"S Schroeder","year":"2009","unstructured":"Schroeder\u00a0S, Hochreiter\u00a0M, Koehler\u00a0T, Schweiger\u00a0A\u2011M, Bein\u00a0B, Keck\u00a0FS, et al. Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a\u00a0prospective randomized study. Langenbecks Arch Surg. 2009;394(2):221\u20136.","journal-title":"Langenbecks Arch Surg"},{"key":"1747_CR7","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/1471-2334-13-158","volume":"13","author":"A Hohn","year":"2013","unstructured":"Hohn\u00a0A, Schroeder\u00a0S, Gehrt\u00a0A, Bernhardt\u00a0K, Bein\u00a0B, Wegscheider\u00a0K, et al. Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock. BMC Infect Dis. 2013;13:158.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"1747_CR8","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1164\/rccm.200708-1238OC","volume":"177","author":"V Nobre","year":"2008","unstructured":"Nobre\u00a0V, Harbarth\u00a0S, Graf\u00a0J\u2011D, Rohner\u00a0P, Pugin\u00a0J. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a\u00a0randomized trial. Am J Respir Crit Care Med. 2008;177(5):498\u2013505.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"1747_CR9","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1183\/09031936.00053209","volume":"34","author":"D Stolz","year":"2009","unstructured":"Stolz\u00a0D, Smyrnios\u00a0N, Eggimann\u00a0P, Pargger\u00a0H, Thakkar\u00a0N, Siegemund\u00a0M, et al. Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a\u00a0randomised study. Eur Respir\u00a0J. 2009;34(6):1364\u201375.","journal-title":"Eur Respir J"},{"issue":"8","key":"1747_CR10","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1097\/CCM.0b013e318251517a","volume":"40","author":"N Layios","year":"2012","unstructured":"Layios\u00a0N, Lambermont\u00a0B, Canivet\u00a0J\u2011L, Morimont\u00a0P, Preiser\u00a0J\u2011C, Garweg\u00a0C, et al. Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients. Crit Care Med. 2012;40(8):2304\u20139.","journal-title":"Crit Care Med"},{"issue":"10","key":"1747_CR11","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1097\/CCM.0b013e31828e969f","volume":"41","author":"CF Oliveira","year":"2013","unstructured":"Oliveira\u00a0CF, Botoni\u00a0FA, Oliveira\u00a0CRA, Silva\u00a0CB, Pereira\u00a0HA, Serufo\u00a0JC, et al. Procalcitonin versus C\u2011reactive protein for guiding antibiotic therapy in sepsis: a\u00a0randomized trial. Crit Care Med. 2013;41(10):2336\u201343.","journal-title":"Crit Care Med"},{"issue":"3","key":"1747_CR12","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.diagmicrobio.2013.03.027","volume":"76","author":"RO Deliberato","year":"2013","unstructured":"Deliberato\u00a0RO, Marra\u00a0AR, Sanches\u00a0PR, Martino\u00a0MDV, dos Santos Ferreira\u00a0CE, Pasternak\u00a0J, et\u00a0al. Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting. Diagn Microbiol Infect Dis. 2013;76(3):266\u201371.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"10","key":"1747_CR13","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1164\/rccm.201408-1483OC","volume":"190","author":"Y Shehabi","year":"2014","unstructured":"Shehabi\u00a0Y, Sterba\u00a0M, Garrett\u00a0PM, Rachakonda\u00a0KS, Stephens\u00a0D, Harrigan\u00a0P, et\u00a0al. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial. Am J Respir Crit Care Med. 2014;190(10):1102\u201310.","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"1747_CR14","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/jamainternmed.2016.2514","volume":"176","author":"F Bloos","year":"2016","unstructured":"Bloos\u00a0F, Trips\u00a0E, Nierhaus\u00a0A, Briegel\u00a0J, Heyland\u00a0DK, Jaschinski\u00a0U, et al. Effect of sodium selenite administration and procalcitonin-guided therapy on mortality in patients with severe sepsis or septic shock: a randomized clinical trial. JAMA Intern Med. 2016;176(9):1266\u201376.","journal-title":"JAMA Intern Med"},{"issue":"2","key":"1747_CR15","doi-asserted-by":"publisher","first-page":"e002186","DOI":"10.1136\/bmjopen-2012-002186","volume":"3","author":"D Annane","year":"2013","unstructured":"Annane\u00a0D, Maxime\u00a0V, Faller\u00a0JP, Mezher\u00a0C, Clec\u2019h\u00a0C, Martel\u00a0P, et al. Procalcitonin levels to guide antibiotic therapy in adults with non-microbiologically proven apparent severe sepsis: a randomised controlled trial. BMJ Open. 2013;3(2):e2186. https:\/\/doi.org\/10.1136\/bmjopen-2012-002186.","journal-title":"BMJ Open"},{"issue":"1","key":"1747_CR16","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13613-017-0338-6","volume":"7","author":"H-B Huang","year":"2017","unstructured":"Huang\u00a0H\u2011B, Peng\u00a0J\u2011M, Weng\u00a0L, Wang\u00a0C\u2011Y, Jiang\u00a0W, Du\u00a0B. Procalcitonin-guided antibiotic therapy in intensive care unit patients: a\u00a0systematic review and meta-analysis. Ann Intensive Care. 2017;7(1):114.","journal-title":"Ann Intensive Care"},{"issue":"1","key":"1747_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13054-018-2125-7","volume":"22","author":"Y Wirz","year":"2018","unstructured":"Wirz\u00a0Y, Meier\u00a0MA, Bouadma\u00a0L, Luyt\u00a0CE, Wolff\u00a0M, Chastre\u00a0J, et al. Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a\u00a0patient-level meta-analysis of randomized trials. Crit Care. 2018;22(1):191.","journal-title":"Crit Care"},{"issue":"9","key":"1747_CR18","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1515\/cclm-2018-1181","volume":"57","author":"P Schuetz","year":"2019","unstructured":"Schuetz\u00a0P, Beishuizen\u00a0A, Broyles\u00a0M, Ferrer\u00a0R, Gavazzi\u00a0G, Gluck\u00a0EH, et al. Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use. Clin Chem Lab Med. 2019;57(9):1308\u201318.","journal-title":"Clin Chem Lab Med"},{"issue":"12","key":"1747_CR19","doi-asserted-by":"publisher","first-page":"e573","DOI":"10.1016\/S2352-3026(17)30211-9","volume":"4","author":"M Aguilar-Guisado","year":"2017","unstructured":"Aguilar-Guisado\u00a0M, Espigado\u00a0I, Mart\u00edn-Pe\u00f1a\u00a0A, Gudiol\u00a0C, Royo-Cebrecos\u00a0C, Falantes\u00a0J, et al. Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (how long study): an open-label, randomised, controlled phase 4 trial. Lancet Haematol. 2017;4(12):e573\u201383.","journal-title":"Lancet Haematol"},{"issue":"8","key":"1747_CR20","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer\u00a0M, Deutschman\u00a0CS, Seymour\u00a0CW, Shankar-Hari\u00a0M, Annane\u00a0D, Bauer\u00a0M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"key":"1747_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/kisup.2012.1","volume":"2","author":"KDIGO","year":"2012","unstructured":"KDIGO. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1\u2013138.","journal-title":"Kidney Int Suppl"},{"issue":"10","key":"1747_CR22","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","volume":"13","author":"WA Knaus","year":"1985","unstructured":"Knaus\u00a0WA, Draper\u00a0EA, Wagner\u00a0DP, Zimmerman\u00a0JE. APACHE II: a\u00a0severity of disease classification system. Crit Care Med. 1985;13(10):818\u201329.","journal-title":"Crit Care Med"},{"issue":"11","key":"1747_CR23","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1097\/00003246-199811000-00016","volume":"26","author":"JL Vincent","year":"1998","unstructured":"Vincent\u00a0JL, de Mendon\u00e7a\u00a0A, Cantraine\u00a0F, Moreno\u00a0R, Takala\u00a0J, Suter\u00a0PM, et al. Use of the SOFA score to assess the incidence of organ dysfunction\/failure in intensive care units: results of a\u00a0multicenter, prospective study. Working group on \u201csepsis-related problems\u201d of the European society of intensive care medicine. Crit Care Med. 1998;26(11):1793\u2013800.","journal-title":"Crit Care Med"},{"key":"1747_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1741-7015-9-107","volume":"9","author":"P Schuetz","year":"2011","unstructured":"Schuetz\u00a0P, Albrich\u00a0W, Mueller\u00a0B. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med. 2011;9:107.","journal-title":"BMC Med"},{"issue":"3","key":"1747_CR25","doi-asserted-by":"publisher","first-page":"030705","DOI":"10.11613\/BM.2019.030705","volume":"29","author":"I Lapi\u0107","year":"2019","unstructured":"Lapi\u0107\u00a0I, Rogi\u0107\u00a0D, Fu\u010dek\u00a0M, Galovi\u0107\u00a0R. Effectiveness of minimum retesting intervals in managing repetitive laboratory testing: experience from a Croatian university hospital. Biochem Med. 2019;29(3):30705.","journal-title":"Biochem Med"},{"key":"1747_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12910-016-0092-6","volume":"17","author":"S Rebers","year":"2016","unstructured":"Rebers\u00a0S, Aaronson\u00a0NK, van Leeuwen\u00a0FE, Schmidt\u00a0MK. Exceptions to the rule of informed consent for research with an intervention. BMC Med Ethics. 2016;17:9.","journal-title":"BMC Med Ethics"},{"issue":"4","key":"1747_CR27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3343\/alm.2014.34.4.263","volume":"34","author":"M Meisner","year":"2014","unstructured":"Meisner\u00a0M. Update on procalcitonin measurements. Ann Lab Med. 2014;34(4):263\u201373.","journal-title":"Ann Lab Med"},{"issue":"9","key":"1747_CR28","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s001340000624","volume":"26","author":"K Reinhart","year":"2000","unstructured":"Reinhart\u00a0K, Karzai\u00a0W, Meisner\u00a0M. Procalcitonin as a\u00a0marker of the systemic inflammatory response to infection. Intensive Care Med. 2000;26(9):1193\u2013200.","journal-title":"Intensive Care Med"},{"issue":"1","key":"1747_CR29","doi-asserted-by":"publisher","first-page":"ofw249","DOI":"10.1093\/ofid\/ofw249","volume":"4","author":"C Rhee","year":"2017","unstructured":"Rhee\u00a0C. Using procalcitonin to guide antibiotic therapy. Open Forum Infect Dis. 2017;4(1):ofw249.","journal-title":"Open Forum Infect Dis"},{"key":"1747_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4103\/1735-1995.183996","volume":"21","author":"S Li","year":"2016","unstructured":"Li\u00a0S, Rong\u00a0H, Guo\u00a0Q, Chen\u00a0Y, Zhang\u00a0G, Yang\u00a0J. Serum procalcitonin levels distinguish Gram-negative bacterial sepsis from Gram-positive bacterial and fungal sepsis. J\u00a0Res Med Sci. 2016;21:39.","journal-title":"J Res Med Sci"},{"issue":"10","key":"1747_CR31","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1080\/10428194.2019.1581928","volume":"60","author":"X Luo","year":"2019","unstructured":"Luo\u00a0X, Chen\u00a0S, Zhang\u00a0J, Ren\u00a0J, Chen\u00a0M, Lin\u00a0K, et al. Procalcitonin as a\u00a0marker of Gram-negative bloodstream infections in hematological patients with febrile neutropenia. Leuk Lymphoma. 2019;60(10):2441\u20138.","journal-title":"Leuk Lymphoma"},{"key":"1747_CR32","first-page":"CD010959","volume":"1","author":"BN Andriolo","year":"2017","unstructured":"Andriolo\u00a0BN, Andriolo\u00a0RB, Salom\u00e3o\u00a0R, Atallah \u00c1N. Effectiveness and safety of procalcitonin evaluation for reducing mortality in adults with sepsis, severe sepsis or septic shock. Cochrane Database Syst Rev. 2017;1:CD10959.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1747_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0885066610395678","volume":"26","author":"RS Jawa","year":"2011","unstructured":"Jawa\u00a0RS, Anillo\u00a0S, Huntoon\u00a0K, Baumann\u00a0H, Kulaylat\u00a0M. Analytic review: interleukin\u20116 in surgery, trauma, and critical care: part I: basic science. J\u00a0Intensive Care Med. 2011;26(1):3\u201312.","journal-title":"J Intensive Care Med"},{"issue":"2","key":"1747_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/0885066610384188","volume":"26","author":"RS Jawa","year":"2011","unstructured":"Jawa\u00a0RS, Anillo\u00a0S, Huntoon\u00a0K, Baumann\u00a0H, Kulaylat\u00a0M. Interleukin\u20116 in surgery, trauma, and critical care part II: clinical implications. J\u00a0Intensive Care Med. 2011;26(2):73\u201387.","journal-title":"J Intensive Care Med"},{"issue":"4","key":"1747_CR35","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1515\/cclm-2014-0607","volume":"53","author":"DW Jekarl","year":"2015","unstructured":"Jekarl\u00a0DW, Kim\u00a0JY, Lee\u00a0S, Kim\u00a0M, Kim\u00a0Y, Han\u00a0K, et\u00a0al. Diagnosis and evaluation of severity of sepsis via the use of biomarkers and profiles of 13 cytokines: a\u00a0multiplex analysis. Clin Chem Lab Med. 2015;53(4):575\u201381.","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"1747_CR36","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cyto.2004.10.010","volume":"29","author":"S Oda","year":"2005","unstructured":"Oda\u00a0S, Hirasawa\u00a0H, Shiga\u00a0H, Nakanishi\u00a0K, Matsuda\u00a0K, Nakamua\u00a0M. Sequential measurement of IL\u20116 blood levels in patients with systemic inflammatory response syndrome (SIRS)\/sepsis. Cytokine. 2005;29(4):169\u201375.","journal-title":"Cytokine"},{"issue":"1","key":"1747_CR37","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12879-019-3800-2","volume":"19","author":"L Weidhase","year":"2019","unstructured":"Weidhase\u00a0L, Wellh\u00f6fer\u00a0D, Schulze\u00a0G, Kaiser\u00a0T, Drogies\u00a0T, Wurst\u00a0U, et al. Is interleukin\u20116 a\u00a0better predictor of successful antibiotic therapy than procalcitonin and C\u2011reactive protein? A single center study in critically ill adults. BMC Infect Dis. 2019;19(1):150.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"1747_CR38","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1164\/ajrccm.164.3.2009052","volume":"164","author":"S Harbarth","year":"2001","unstructured":"Harbarth\u00a0S, Holeckova\u00a0K, Froidevaux\u00a0C, Pittet\u00a0D, Ricou\u00a0B, Grau\u00a0GE, et al. Diagnostic value of procalcitonin, interleukin\u20116, and interleukin\u20118 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med. 2001;164(3):396\u2013402.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"1747_CR39","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s13054-020-02993-5","volume":"24","author":"C Pierrakos","year":"2020","unstructured":"Pierrakos\u00a0C, Velissaris\u00a0D, Bisdorff\u00a0M, Marshall\u00a0JC, Vincent\u00a0J\u2011L. Biomarkers of sepsis: time for a\u00a0reappraisal. Crit Care. 2020;24(1):287.","journal-title":"Crit Care"},{"issue":"19","key":"1747_CR40","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.4155\/bio-2019-0192","volume":"11","author":"SK Fischer","year":"2019","unstructured":"Fischer\u00a0SK, Williams\u00a0K, Wang\u00a0L, Capio\u00a0E, Briman\u00a0M. Development of an IL-6\u00a0point-of-care assay: utility for real-time monitoring and management of cytokine release syndrome and sepsis. Bioanalysis. 2019;11(19):1777\u201385.","journal-title":"Bioanalysis"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-020-01747-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-020-01747-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-020-01747-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T04:46:45Z","timestamp":1633495605000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-020-01747-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,6]]},"references-count":40,"journal-issue":{"issue":"15-16","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1747"],"URL":"https:\/\/doi.org\/10.1007\/s00508-020-01747-1","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"type":"print","value":"0043-5325"},{"type":"electronic","value":"1613-7671"}],"subject":[],"published":{"date-parts":[[2020,10,6]]},"assertion":[{"value":"23 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical guidelines"}},{"value":"A.\u00a0Vujaklija Brajkovi\u0107, I.\u00a0Ko\u0161uta, D.\u00a0Tomek, M.\u00a0Rora, J.\u00a0Babel, D.\u00a0Rogi\u0107, A.\u00a0Lon\u010dar Vran\u010di\u0107, and R.\u00a0Radoni\u0107 declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Ethics Committee of the University Hospital Centre Zagreb approved this research as a\u00a0non-sponsored prospective epidemiological study. Considering the design of the study and possible exceptions to the rule of informed consent, the informed consent was waived for the present study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}